View Item 

Show simple item record

Plasma Adrenaline: Relations to Blood Pressure, Blood Platelet Function and Blood Lipids in Essential Hypertension
dc.contributor.authorKjeldsen, Sverre E.en_US
dc.contributor.authorLande, Knuten_US
dc.contributor.authorGjesdal, Knuten_US
dc.contributor.authorLeren, Paulen_US
dc.contributor.authorEide, Ivar K.en_US
dc.date.accessioned2010-06-01T18:17:45Z
dc.date.available2010-06-01T18:17:45Z
dc.date.issued1988-08en_US
dc.identifier.citationKjeldsen, Sverre E.; Lande, Knut; Gjesdal, Knut; Leren, Paul; Eide, Ivar K. (1988). "Plasma Adrenaline: Relations to Blood Pressure, Blood Platelet Function and Blood Lipids in Essential Hypertension." Pharmacology & Toxicology 63(s1): 35-37. <http://hdl.handle.net/2027.42/71506>en_US
dc.identifier.issn0901-9928en_US
dc.identifier.issn1600-0773en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71506
dc.format.extent206990 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1988 Nordic Pharmacological Societyen_US
dc.subject.otherAdrenalineen_US
dc.subject.otherBlood Pressureen_US
dc.subject.otherCatecholaminesen_US
dc.subject.otherHeart Rateen_US
dc.subject.otherHypertensionen_US
dc.subject.otherLipoproteinsen_US
dc.subject.otherNoradrenalineen_US
dc.subject.otherPlatelet Functionen_US
dc.subject.otherSympathetic Toneen_US
dc.titlePlasma Adrenaline: Relations to Blood Pressure, Blood Platelet Function and Blood Lipids in Essential Hypertensionen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Internal Medicine, Division of Hypertension, The University of Michigan Medical Center, 3918 Taubman Center, Ann Arbor, MI 48109-0356, USAen_US
dc.contributor.affiliationotherDepartment of Internal Medicine, Oslo University Medical School, Ullevaal Hospital, Oslo, Norwayen_US
dc.identifier.pmid3200793en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71506/1/j.1600-0773.1988.tb02036.x.pdf
dc.identifier.doi10.1111/j.1600-0773.1988.tb02036.xen_US
dc.identifier.sourcePharmacology & Toxicologyen_US
dc.identifier.citedreferenceKjeldsen S. E., Flaaten B., Eide I., Helgeland A., Leren P.: Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension. Scand J Clin Lab Invest 42: 217 – 223 ( 1982 ).en_US
dc.identifier.citedreferenceKjeldsen S. E., Eide I., Aakesson I., Leren P.: Increased arterial catecholamine concentrations in 50-year-old men with essential hypertension. Scand J Clin Lab Invest 43: 343 – 349 ( 1983 ).en_US
dc.identifier.citedreferenceMÖrlin C., Wallin B. G., Eriksson B. M.: Muscle sympathetic activity and plasma noradrenaline in normotensive and hypertensive man. Acta Physiol Scand 119: 117 – 121 ( 1983 ).en_US
dc.identifier.citedreferenceJulius S., Pascual A. V., London R.: Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation 44: 413 – 418 ( 1971 ).en_US
dc.identifier.citedreferenceKjeldsen S. E., Gjesdal K., Eide I., Aakesson I., Amundsen R., Foss O. P., Leren P.: Increased Β-thromboglobulin in essential hypertension: interactions between arterial plasma adrenaline, platelet function and blood lipids. Acta Med Scand 213: 369 – 373 ( 1983 ).en_US
dc.identifier.citedreferenceLande K., Kjeldsen S. E., Os I., Westheim A., Hjermann I., Eide I., Gjesdal K.: Increased platelet and vascular smooth muscle reactivity to low-dose adrenaline infusion in mild essential hypertension. J Hypertens, 6: 219 – 225 ( 1988 ).en_US
dc.identifier.citedreferenceHollister A. S., Onrot J., Lonce S., Nadeau JHJ, Robertson D. Plasma catecholamine modulation of alpha-2 adrenoceptor agonist affinity and sensitivity in normotensive and hypertensive human platelets. J Clin Invest 11: 1416 – 1421 ( 1986 ).en_US
dc.identifier.citedreferencePatsch J. R., Gotto A. M., Olivecrona T., Eisenberg S.: Formation of high density lipoprotein 2 -like particles during lipolysis of very low density lipoprotein in vitro. Proc Natl Acad Sci 75: 4519 – 4523 ( 1978 ).en_US
dc.identifier.citedreferenceKjeldsen S. E., Eide I., Leren P., Foss O. P., Holme I., Eriksen I. L.: The effect of HDL cholesterol of oxprenolol and atenolol. Scand J Clin Lab Invest 42: 449 – 453 ( 1982 ).en_US
dc.identifier.citedreferenceAshby P., Parkin S., Walker K., Bennett D. P., Robinson D. S.: Hormonal control of adipose tissue lipoprotein lipase activity. INSERM Symposia 87: 149 – 159 ( 1979 ).en_US
dc.identifier.citedreferenceDay J. L., Metcalfe J., Simpson C. N.: Adrenergic mechanisms in control of plasma lipid concentrations. Br Med J 284: 1145 – 1148 ( 1982 ).en_US
dc.identifier.citedreferenceDimsdale J. E., Herd A., Hartley H.: Epinephrine mediated increases in plasma cholesterol. Psychosomatic Med 45: 227 – 232 ( 1983 ).en_US
dc.identifier.citedreferenceLeren P., Foss O. P., Helgeland A., Hjermann I., Holme I., Lund-Larsen P. G.: Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet ii: 4 – 6 ( 1980 ).en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-0773.1988.tb02036.x.pdf
Size:
202.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.